India: E-Pharmacy - Legal Sanctity?

Last Updated: 20 December 2016
Article by Rajesh Begur and Priyesh Sharma

While the economy is witnessing a fast transition from "offline" to "online" markets and there is a sturdy buzz of "demonetization" and "one click" access to everything, yet laws relating to regulation of most of these e-commerce businesses are in a very nascent stage. The growth in usage of new technology and digitalization to disrupt the marketplace of traditional institutions and intermediaries in the delivery of services have significantly touched upon all industries including pharmaceutical sector wherein the fintech has given rise to a lot of budding e-pharmacies businesses.  There are various business models on e-pharmacies which are being adopted by start-ups as well as established players in the market, however the absence of definite legislations regulating these business models has started raising serious concerns over the black hole in our regulatory framework and the Government departments certainly need to gear up and come out with definite regulatory framework for these business models without any further delay. This update is an attempt to analyse the legal sanctity of such existing business models of e-pharmacies in India.

Indian pharmaceutical laws have not kept pace with the developing e-commerce market and the Government has not framed any specific legislation to regulate online distribution/ sale of drugs yet. In fact, we have no laws that can effectively deal with legal issues like sanctity of online pharmacies, distribution of drugs without proper prescriptions, whole sale or retail e-trading of drugs to name a few. The issue gains prominence when we talk about "Schedule X" Drugs i.e. the drugs which cannot be sold without the authorized prescription from medical practitioners and are specifically named under Schedule X of the Drugs and Cosmetics Act of 1940 ("D&C Act"). With the recent controversies involving renowned market players, for instance the Snap deal controversy, wherein it was came to the notice of state FDA that the restricted drugs were being sold freely online without any requirement of prescription, and the on-going public interest suit in Bombay High Court, the issue has gained a lot of public visibility.

Existing Legal Framework on E-Distribution of Drugs in India: Indian Laws relating to pharmacies were written prior to arrival computers, let alone internet. There are no dedicated e-health and telemedicine laws in India. Even essential attributes of these laws like regulatory requirements, cyber security data security, etc. are not governed by much needed dedicated laws.  Whereas physical means of conducting such businesses are very well regulated under the various pharmaceutical laws and legislations in India, the online mode is still largely unregulated. Other than a circular issued by the Drugs Controller General of India on December 30, 2015 ("DCGI Circular"), wherein it has been referred that the online pharmacists should comply with the D&C Act requirements and has directed the state FDAs on take strict action against any unauthorized online sale of drugs, , the law however is silent on permissibility of e-distribution aspect of the same and requirement of specific compliances and restrictions.

Numerous statues carry individual provisions that may be (or at least may be interpreted to be!) applicable to e-health and telemedicine activities in India. For instance, there are many techno legal requirements pertaining to privacy, data protection, encryption, cyber law due diligence, internet intermediary obligations, cloud computing, etc. that are required to be complied with by online pharmacy stores operating in India.

The "Gray" Area: One direct consequence (if not be termed as an "advantage" or "disadvantage") of absence of explicit regulatory framework is that there is no express permission or prohibition to carry out such business models. Hence the legality of online sale of drugs remains unclear and there exists a "gray" zone. Moreover, other than the recent actions taken by respective state FDAs on several such e-commerce businesses, there is no judicial pronouncement on the subject till date.

Critical Concerns: In addition to the issue of ambiguity and applicability of laws, there are several other concerns relating to legal and business viability of e-distribution model for drugs in India. For example, unlike other e-commerce products/services, "pharmaceutical industry" is categorized as "high risk" sector by the Reserve Bank of India and payment gateways generally don't accept online payments for medicines, however the same depends upon case to case basis and quantum of security. Further, the issue of authenticating or checking the validity of scanned copies of prescriptions is not full proof and the possibility of usage of fake or amended copies of prescriptions cannot be overruled. Moving towards the penal consequences, pharmaceutical laws are known for the strictest penalties whether in terms of monetary penalties or imprisonment for non-compliances. Also, FDAs are witnessed to have been very strict in terms of any non-compliance or complaints against such business activities. States FDAs like Karnataka FDA and Maharashtra FDA have set examples of strict actions like complete shutting down of business activities for any non-compliance. Lastly, drugs and medicines, being essential and critical products, it will require quite some time for Indian consumers to repose their faith and confidence on online models for purchase and delivery of such products. Equally challenging would be live-up to that faith and confidence!

Precautionary Measures to be followed while carrying out such Business without Encroaching the Illegal Territory: As said previously, the business model of e-distribution of drugs is not illegal in India. Individuals and companies may explore the e-distribution of drugs option, provided that they don't fall foul of the existing pharmaceutical and IT legislations. Hence, set out below are some of the precautionary measures which the businesses should consider and follow to remain within the ambit of law while carrying out such activities: 

  • Strict compliance/ conservative view would be to hold a "retail license" even for e-distribution of drugs. Note that a retail drug license is only issued to persons who possess a degree or diploma in pharmacy from a recognized institute or university. Medibiz controversy in Karnataka also supports the above view.
  • Online pharmacies/drugs distribution websites can be categorized as "internet intermediaries" within the meaning of Information Technology Act, 2000 ("IT Act") and are therefore required to comply with cyber law due diligence requirements in India.
  • As per D&C Act, there is no concept of "digital prescriptions". While as per the IT Act, digital documents have full legal sanctity and this IT Act takes precedence over all other acts where digital documents are in question. Therefore, it is better to obtain a copy of digital prescription as a condition precedent to accepting any order for e-sale/distribution of Schedule X drug. Further, it is advisable to verify the physical copy of the prescription during the time of delivery.
  • Arrangements and tie ups should be done only with licensed pharmacies. Further, orders should be taken and accepted from the customer(s) either over the phone or internet only from the areas where the pharmacy retail license is applicable.
  • Ideally, the medicines/drugs need to be delivered to the customers by a registered pharmacist, not the courier person. However a more feasible option for distribution is to tie up with a firm which possesses distribution license. Alternatively, distribution can be carries out by licensed pharmacies directly.
  • As far as payment option is concerned, it is recommended to negotiate for prepayment mechanisms with banks and/or other payment gateways.  If not allowed, then Cash on Delivery is still an available and legally valid option.

Way Ahead:

The annual Indian pharmaceutical market is pegged at around USD 36.4 Billion, steadily growing at around 20% per annum. If the Government decides to allow online sale of drugs, it is likely to give a major boost to sales of the sector while also making medicines accessible to remote areas. Also, with the on-going steps towards demonetization of Indian economy, proper regulations and legal framework for such online businesses is a need of the hour.

Pursuant to on-going public interest suits in judicial forums and various instances of unauthorized online sale of restricted drugs in India, there is a possibility that strict regulations or even a ban on such businesses may be imposed by Government in near future. However the Government is also considering launching a pilot project to regulate the online sale of drugs to be equipped with proper regulation mechanism instead of imposing any blanket restriction or ban on the same. The central regulator is also consulting various international drug regulatory agencies such as the US FDA and the European Medicines Agency as well as examining their models to understand how quality and standards of medicines sold through e-commerce portals are monitored in these countries. Once the definite regulations are out, the sector will be better regulated and expected to grow swiftly!

While on the one hand there has been a continuous call for regulations because the existing laws does not have any specific guidelines in place for e-commerce players in the pharmaceutical industry. It is still very clear that 'scheduled' drugs should be sold only by licensed pharmacies against a doctor's prescription. This is in consonance with the DCGI Circular also. Therefore for the time being, any business model on e-sale/distribution of drugs (especially Schedule X drugs) should comply with the above mentioned precautionary measures to the extent possible in order to avoid any serious repercussions under applicable laws.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions